🔎 Trials Near Me

Home › Kidney Diseases

Kidney Diseases clinical trials recruiting in the U.S.

50 studies for Kidney Diseases are recruiting participants at sites across the United States.

Properly functioning kidneys are critical for maintaining good health. Diabetes, high blood pressure, or family history can increase risk of kidney disease.

Cities with the most studies

By state

Recently updated studies

Immune System Related Kidney Disease

RecruitingObservational study
Ages 10 to 99 · All sexes · Updated Nov 12, 2026 · NCT00001979

Pediatric Longitudinal Glomerular Disease: a PNRC Multi-Institutional Cohort Study

RecruitingObservational study
Up to age 18 · All sexes · Updated Nov 12, 2026 · NCT07931170

Optimizing Referral Pathways for Patients With Hematuria and Moderate-Severe Proteinuria

Recruiting
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07431931

A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population

RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07006831

NightWare and Cardiovascular Health in Women With PTSD

RecruitingHealthy volunteers welcome
Ages 22 to 40 · Women · Updated Nov 6, 2026 · NCT07021014

A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia

RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Nov 6, 2026 · NCT06525636

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06963827

A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07902817

Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT06798909

Autonomic and Renal Contributions to Hypertension With ADT

RecruitingPhase 4Healthy volunteers welcome
Ages 40 and older · Men · Updated Nov 2, 2026 · NCT07848828

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Oct 30, 2026 · NCT07541287

An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases

RecruitingPhase 2
Ages 18 to 115 · All sexes · Updated Oct 30, 2026 · NCT06664814

Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

RecruitingPhase 2
Ages 18 to 90 · All sexes · Updated Oct 26, 2026 · NCT00977977

Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

RecruitingObservational study
Ages 21 and older · All sexes · Updated Oct 22, 2026 · NCT07059962

SPYRAL GEMINI Pilot Study

Recruiting
Ages 18 to 80 · All sexes · Updated Oct 20, 2026 · NCT06907147

PS-002 for the Treatment of IgA Nephropathy in Adults

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07182227

Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.

Recruiting
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06374537

The Effects of the CF Carrier State on the Kidneys and Pancreas

RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT05474417

Duke APOL1 Research Biorepository

RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT04160507

Enhancing Physical Function in Older Adults With Chronic Kidney Disease

Recruiting
Ages 65 to 100 · All sexes · Updated Aug 26, 2026 · NCT06738394

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Aug 17, 2026 · NCT06858319

Pedal Pump Clinical Trial on Edema V1

Recruiting
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07760363

NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities

Recruiting
Ages 18 to 75 · All sexes · Updated Jul 24, 2026 · NCT06810622

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.